CASE REPORT
Published on 30 Sep 2025
Case Report: A case of reversible pulmonary bullae induced by camrelizumab: a new immune-related adverse event
doi 10.3389/fimmu.2025.1619702
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Cancer Therapy Related Organ Toxicities
Cancer Therapy Related Organ Toxicities
5,595
Total downloads
27k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 25 Sep 2025
Increased acid sphingomyelinase levels in saliva as oral mucositis severity predictors
doi 10.3389/fonc.2025.1613884
- 2,167 views
ORIGINAL RESEARCH
Accepted on 22 Sep 2025
Immune checkpoint inhibitor-associated aseptic meningitis: A pharmacovigilance study using the FDA adverse event reporting system (2011-2024)
doi 10.3389/fimmu.2025.1654301
- 137 views
ORIGINAL RESEARCH
Accepted on 18 Sep 2025
Risk factors for steroid-refractory in immune checkpoint inhibitor-induced colitis: a retrospective cohort study
doi 10.3389/fimmu.2025.1623150
CASE REPORT
Published on 10 Sep 2025
Successful rescue of PD-1 inhibitor-induced TEN by vincristine combination therapy: a case report and literature review
doi 10.3389/fonc.2025.1621494
- 468 views
CASE REPORT
Accepted on 09 Sep 2025
Immune-related Osteitis mimicking Femoral Head Osteonecrosis during Dual Checkpoint Blockade: A case report
doi 10.3389/fonc.2025.1621774
- 140 views
ORIGINAL RESEARCH
Published on 13 Aug 2025
Clinical features and risk factors of immune-mediated liver injury in non-small cell lung cancer patients treated with immune checkpoint inhibitors
doi 10.3389/fonc.2025.1575376
- 818 views
CASE REPORT
Published on 25 Jun 2025
Case Report: Immune checkpoint inhibitor-induced myositis without elevated creatine kinase
doi 10.3389/fimmu.2025.1592385
- 1,410 views
ORIGINAL RESEARCH
Published on 09 Jun 2025
Insights into immune-related adverse events in colorectal cancer patients receiving neoadjuvant immunotherapy: findings from a multicenter registry study
doi 10.3389/fimmu.2025.1529637
- 1,998 views
ORIGINAL RESEARCH
Published on 28 Apr 2025
Moderate toxicity with late onset as a good omen: association between toxicity and survival in the checkpoint inhibitor immunotherapy—a single center experience
doi 10.3389/fimmu.2025.1527103
- 1,398 views
CASE REPORT
Published on 04 Apr 2025
Case Report: Successful use of emapalumab in adult B-cell acute lymphoblastic leukemia experiencing severe neurotoxicity and hemophagocytic lymphohistiocytosis-like features after CAR-T cell therapy
doi 10.3389/fimmu.2025.1563736
- 4,825 views
- 1 citation
CASE REPORT
Published on 01 Apr 2025
Immune checkpoint inhibitor-induced anti-Hu antibody-associated gastrointestinal pseudo-obstruction: a case report and literature review
doi 10.3389/fimmu.2025.1555790
- 1,822 views
- 2 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore